# Discriminator report

## Scenario echo
Human pancreas, all cell types in the tissue, with age, sex, and condition unspecified and no additional notes. The embedding should therefore cover the canonical healthy human pancreas landscape: endocrine islet cells, exocrine acinar and ductal/centroacinar epithelium, vasculature, stromal/mural cells, resident immune cells, adipose/mesothelial components, neural/glial cells, and common cell states.

## Rating: minor
The blueprint is broadly biologically plausible and has strong coverage of the major pancreatic epithelial, endocrine, stromal, vascular, immune, and neural compartments. Targeted edits would improve vascular resolution and prevent a healthy-pancreas ductal axis from leaning too strongly into metaplastic or disease-associated mucin biology.

## Findings

### Minor issues
- **axis/module: venous_capillary_endothelial and venous_capillary_endothelial_within_vascular** - The current endothelial refinement merges venous and capillary/fenestrated endothelial identities into one module/axis. In pancreas, capillary/fenestrated endothelial cells, including islet-associated capillary programs, are a meaningful expected vascular component and should not be collapsed with ACKR1-like venous endothelium.
  *Fix:* Split this into separate gated endothelial axes: one capillary/fenestrated/islet-capillary module using markers such as PLVAP, CA4, RGCC, EMCN, RAMP2, KDR/FLT1 as appropriate, and one venous module enriched for venous markers such as ACKR1, VWF, EPHB4/NR2F2 or related venous genes. Keep arterial and lymphatic branches as sibling endothelial refinements.
- **module/axis: ductal_secretory_mucin and ductal_secretory_mucin_within_ductal** - The mucin/secretory ductal module includes several genes more suggestive of gastric/intestinal metaplasia or mucinous disease/injury programs, especially TFF1, TFF2, and MUC5B, which risks over-representing a non-baseline ductal state in a healthy, condition-null pancreas scenario.
  *Fix:* Retune this module toward normal pancreatic ductal/large-duct or secretory duct biology, or explicitly make it a low-emphasis ductal injury/metaplastic state. If keeping a normal mucin/secretory duct axis, emphasize markers such as MUC1, MUC4, TFF3, AGR2, AGR3, CLDN18, ANXA4, CFTR/SLC4A4-compatible ductal markers and avoid making TFF1/TFF2/MUC5B primary drivers.

## Out of scope (FYI, not actionable for the Generator)
- I did not check dataset-specific gene presence or expression frequency; this is only a biological plausibility review of the declared modules and axes.

## Summary for the next round
Keep the overall blueprint structure. The next Generator should split venous from capillary/fenestrated endothelial identity under the endothelial branch, and revise the ductal mucin/secretory axis so it better matches healthy human pancreas rather than a metaplastic or disease-skewed ductal program.
